Global Recombinant Therapeutic Antibodies and Proteins Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

1 Market Overview

1.1 Recombinant Therapeutic Antibodies and Proteins Introduction

1.2 Market Analysis by Type

1.2.1 Plasma Protein

1.2.2 Fusion Proteins

1.2.3 Monoclonal Antibodies

1.2.4 Hormones

1.2.5 Enzyme

1.2.6 Coagulation Factors

1.2.7 Others

1.3 Market Analysis by Applications

1.3.1 Oncology

1.3.2 Hematology

1.3.3 Immunology

1.3.4 Endocrinology

1.3.5 Infectious Disease

1.3.6 Cardiovascular Disease

1.3.7 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Abbott

2.1.1 Business Overview

2.1.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Abbott Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Amgen

2.2.1 Business Overview

2.2.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Amgen Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Biogen

2.3.1 Business Overview

2.3.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Biogen Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Eli Lilly

2.4.1 Business Overview

2.4.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Eli Lilly Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Roche

2.5.1 Business Overview

2.5.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Roche Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Johnson and Johnson

2.6.1 Business Overview

2.6.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Merck

2.7.1 Business Overview

2.7.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Merck Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Novo Nordisk

2.8.1 Business Overview

2.8.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Pfizer

2.9.1 Business Overview

2.9.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Pfizer Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Sanofi

2.10.1 Business Overview

2.10.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Sanofi Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Recombinant Therapeutic Antibodies and Proteins Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Recombinant Therapeutic Antibodies and Proteins Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Recombinant Therapeutic Antibodies and Proteins Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Recombinant Therapeutic Antibodies and Proteins Manufacturer Market Share in 2017

3.3.2 Top 6 Recombinant Therapeutic Antibodies and Proteins Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Recombinant Therapeutic Antibodies and Proteins Market Analysis by Regions

4.1 Global Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Market Share by Regions

4.1.1 Global Recombinant Therapeutic Antibodies and Proteins Sales and Market Share by Regions (2013-2018)

4.1.2 Global Recombinant Therapeutic Antibodies and Proteins Revenue and Market Share by Regions (2013-2018)

4.2 North America Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

4.3 Europe Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

4.5 South America Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

5 North America Recombinant Therapeutic Antibodies and Proteins by Countries

5.1 North America Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Market Share by Countries

5.1.1 North America Recombinant Therapeutic Antibodies and Proteins Sales and Market Share by Countries (2013-2018)

5.1.2 North America Recombinant Therapeutic Antibodies and Proteins Revenue and Market Share by Countries (2013-2018)

5.2 United States Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

5.3 Canada Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

5.4 Mexico Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

6 Europe Recombinant Therapeutic Antibodies and Proteins by Countries

6.1 Europe Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Market Share by Countries

6.1.1 Europe Recombinant Therapeutic Antibodies and Proteins Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Recombinant Therapeutic Antibodies and Proteins Revenue and Market Share by Countries (2013-2018)

6.2 Germany Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

6.3 UK Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

6.4 France Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

6.5 Russia Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

6.6 Italy Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

7 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins by Countries

7.1 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Revenue and Market Share by Countries (2013-2018)

7.2 China Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

7.3 Japan Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

7.4 Korea Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

7.5 India Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

8 South America Recombinant Therapeutic Antibodies and Proteins by Countries

8.1 South America Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Market Share by Countries

8.1.1 South America Recombinant Therapeutic Antibodies and Proteins Sales and Market Share by Countries (2013-2018)

8.1.2 South America Recombinant Therapeutic Antibodies and Proteins Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

8.3 Argentina Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

8.4 Colombia Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

9 Middle East and Africa Recombinant Therapeutic Antibodies and Proteins by Countries

9.1 Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

9.3 UAE Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

9.4 Egypt Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

9.5 Nigeria Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

9.6 South Africa Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

10 Global Recombinant Therapeutic Antibodies and Proteins Market Segment by Type

10.1 Global Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Recombinant Therapeutic Antibodies and Proteins Sales and Market Share by Type (2013-2018)

10.1.2 Global Recombinant Therapeutic Antibodies and Proteins Revenue and Market Share by Type (2013-2018)

10.2 Plasma Protein Sales Growth and Price

10.2.1 Global Plasma Protein Sales Growth (2013-2018)

10.2.2 Global Plasma Protein Price (2013-2018)

10.3 Fusion Proteins Sales Growth and Price

10.3.1 Global Fusion Proteins Sales Growth (2013-2018)

10.3.2 Global Fusion Proteins Price (2013-2018)

10.4 Monoclonal Antibodies Sales Growth and Price

10.4.1 Global Monoclonal Antibodies Sales Growth (2013-2018)

10.4.2 Global Monoclonal Antibodies Price (2013-2018)

10.5 Hormones Sales Growth and Price

10.5.1 Global Hormones Sales Growth (2013-2018)

10.5.2 Global Hormones Price (2013-2018)

10.6 Enzyme Sales Growth and Price

10.6.1 Global Enzyme Sales Growth (2013-2018)

10.6.2 Global Enzyme Price (2013-2018)

10.7 Coagulation Factors Sales Growth and Price

10.7.1 Global Coagulation Factors Sales Growth (2013-2018)

10.7.2 Global Coagulation Factors Price (2013-2018)

10.8 Others Sales Growth and Price

10.8.1 Global Others Sales Growth (2013-2018)

10.8.2 Global Others Price (2013-2018)

11 Global Recombinant Therapeutic Antibodies and Proteins Market Segment by Application

11.1 Global Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Application (2013-2018)

11.2 Oncology Sales Growth (2013-2018)

11.3 Hematology Sales Growth (2013-2018)

11.4 Immunology Sales Growth (2013-2018)

11.5 Endocrinology Sales Growth (2013-2018)

11.6 Infectious Disease Sales Growth (2013-2018)

11.7 Cardiovascular Disease Sales Growth (2013-2018)

11.8 Others Sales Growth (2013-2018)

12 Recombinant Therapeutic Antibodies and Proteins Market Forecast (2018-2023)

12.1 Global Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Growth Rate (2018-2023)

12.2 Recombinant Therapeutic Antibodies and Proteins Market Forecast by Regions (2018-2023)

12.2.1 North America Recombinant Therapeutic Antibodies and Proteins Market Forecast (2018-2023)

12.2.2 Europe Recombinant Therapeutic Antibodies and Proteins Market Forecast (2018-2023)

12.2.3 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Forecast (2018-2023)

12.2.4 South America Recombinant Therapeutic Antibodies and Proteins Market Forecast (2018-2023)

12.2.5 Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Market Forecast (2018-2023)

12.3 Recombinant Therapeutic Antibodies and Proteins Market Forecast by Type (2018-2023)

12.3.1 Global Recombinant Therapeutic Antibodies and Proteins Sales Forecast by Type (2018-2023)

12.3.2 Global Recombinant Therapeutic Antibodies and Proteins Market Share Forecast by Type (2018-2023)

12.4 Recombinant Therapeutic Antibodies and Proteins Market Forecast by Application (2018-2023)

12.4.1 Global Recombinant Therapeutic Antibodies and Proteins Sales Forecast by Application (2018-2023)

12.4.2 Global Recombinant Therapeutic Antibodies and Proteins Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

Figure Recombinant Therapeutic Antibodies and Proteins Picture

Table Product Specifications of Recombinant Therapeutic Antibodies and Proteins

Figure Global Sales Market Share of Recombinant Therapeutic Antibodies and Proteins by Types in 2017

Table Recombinant Therapeutic Antibodies and Proteins Types for Major Manufacturers

Figure Plasma Protein Picture

Figure Fusion Proteins Picture

Figure Monoclonal Antibodies Picture

Figure Hormones Picture

Figure Enzyme Picture

Figure Coagulation Factors Picture

Figure Others Picture

Figure Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Applications in 2017

Figure Oncology Picture

Figure Hematology Picture

Figure Immunology Picture

Figure Endocrinology Picture

Figure Infectious Disease Picture

Figure Cardiovascular Disease Picture

Figure Others Picture

Figure United States Recombinant Therapeutic Antibodies and Proteins Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Recombinant Therapeutic Antibodies and Proteins Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Recombinant Therapeutic Antibodies and Proteins Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Recombinant Therapeutic Antibodies and Proteins Revenue (Value) and Growth Rate (2013-2023)

Figure France Recombinant Therapeutic Antibodies and Proteins Revenue (Value) and Growth Rate (2013-2023)

Figure UK Recombinant Therapeutic Antibodies and Proteins Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Recombinant Therapeutic Antibodies and Proteins Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Recombinant Therapeutic Antibodies and Proteins Revenue (Value) and Growth Rate (2013-2023)

Figure China Recombinant Therapeutic Antibodies and Proteins Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Recombinant Therapeutic Antibodies and Proteins Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Recombinant Therapeutic Antibodies and Proteins Revenue (Value) and Growth Rate (2013-2023)

Figure India Recombinant Therapeutic Antibodies and Proteins Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Recombinant Therapeutic Antibodies and Proteins Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Recombinant Therapeutic Antibodies and Proteins Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Recombinant Therapeutic Antibodies and Proteins Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Recombinant Therapeutic Antibodies and Proteins Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Recombinant Therapeutic Antibodies and Proteins Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Recombinant Therapeutic Antibodies and Proteins Revenue (Value) and Growth Rate (2013-2023)

Table Abbott Basic Information, Manufacturing Base and Competitors

Table Abbott Recombinant Therapeutic Antibodies and Proteins Type and Applications

Table Abbott Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Amgen Basic Information, Manufacturing Base and Competitors

Table Amgen Recombinant Therapeutic Antibodies and Proteins Type and Applications

Table Amgen Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Biogen Basic Information, Manufacturing Base and Competitors

Table Biogen Recombinant Therapeutic Antibodies and Proteins Type and Applications

Table Biogen Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Eli Lilly Basic Information, Manufacturing Base and Competitors

Table Eli Lilly Recombinant Therapeutic Antibodies and Proteins Type and Applications

Table Eli Lilly Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Roche Basic Information, Manufacturing Base and Competitors

Table Roche Recombinant Therapeutic Antibodies and Proteins Type and Applications

Table Roche Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Johnson and Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Type and Applications

Table Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck Recombinant Therapeutic Antibodies and Proteins Type and Applications

Table Merck Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novo Nordisk Basic Information, Manufacturing Base and Competitors

Table Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Type and Applications

Table Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Recombinant Therapeutic Antibodies and Proteins Type and Applications

Table Pfizer Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi Basic Information, Manufacturing Base and Competitors

Table Sanofi Recombinant Therapeutic Antibodies and Proteins Type and Applications

Table Sanofi Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Recombinant Therapeutic Antibodies and Proteins Sales by Manufacturer (2016-2017)

Figure Global Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Manufacturer in 2016

Figure Global Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Manufacturer in 2017

Table Global Recombinant Therapeutic Antibodies and Proteins Revenue by Manufacturer (2016-2017)

Figure Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Manufacturer in 2016

Figure Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Manufacturer in 2017

Figure Top 3 Recombinant Therapeutic Antibodies and Proteins Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Recombinant Therapeutic Antibodies and Proteins Manufacturer (Revenue) Market Share in 2017

Figure Global Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

Figure Global Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2013-2018)

Table Global Recombinant Therapeutic Antibodies and Proteins Sales by Regions (2013-2018)

Table Global Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Regions (2013-2018)

Table Global Recombinant Therapeutic Antibodies and Proteins Revenue by Regions (2013-2018)

Figure Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Regions in 2013

Figure Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Regions in 2017

Figure North America Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

Figure Europe Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

Figure South America Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

Figure North America Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2013-2018)

Table North America Recombinant Therapeutic Antibodies and Proteins Sales by Countries (2013-2018)

Table North America Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Countries (2013-2018)

Figure North America Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Countries in 2013

Figure North America Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Countries in 2017

Table North America Recombinant Therapeutic Antibodies and Proteins Revenue by Countries (2013-2018)

Table North America Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries (2013-2018)

Figure North America Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries in 2013

Figure North America Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries in 2017

Figure United States Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

Figure Canada Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

Figure Mexico Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

Figure Europe Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2013-2018)

Table Europe Recombinant Therapeutic Antibodies and Proteins Sales by Countries (2013-2018)

Table Europe Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Countries (2013-2018)

Table Europe Recombinant Therapeutic Antibodies and Proteins Revenue by Countries (2013-2018)

Figure Europe Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries in 2016

Figure Europe Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries in 2017

Figure Germany Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

Figure UK Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

Figure France Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

Figure Russia Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

Figure Italy Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Sales by Countries (2013-2018)

Table Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Countries 2017

Table Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Revenue by Countries (2013-2018)

Figure Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries 2017

Figure China Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

Figure Japan Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

Figure Korea Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

Figure India Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

Figure Southeast Asia Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

Figure South America Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2013-2018)

Table South America Recombinant Therapeutic Antibodies and Proteins Sales by Countries (2013-2018)

Table South America Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Countries (2013-2018)

Figure South America Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Countries in 2017

Table South America Recombinant Therapeutic Antibodies and Proteins Revenue by Countries (2013-2018)

Table South America Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries (2013-2018)

Figure South America Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries in 2017

Figure Brazil Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

Figure Argentina Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

Figure Colombia Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Sales by Countries (2013-2018)

Table Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Countries in 2017

Table Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Revenue by Countries (2013-2018)

Table Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries in 2013

Figure Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries in 2017

Figure Saudi Arabia Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

Figure UAE Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

Figure Egypt Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

Figure Nigeria Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

Figure South Africa Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)

Table Global Recombinant Therapeutic Antibodies and Proteins Sales by Type (2013-2018)

Table Global Recombinant Therapeutic Antibodies and Proteins Sales Share by Type (2013-2018)

Table Global Recombinant Therapeutic Antibodies and Proteins Revenue by Type (2013-2018)

Table Global Recombinant Therapeutic Antibodies and Proteins Revenue Share by Type (2013-2018)

Figure Global Plasma Protein Sales Growth (2013-2018)

Figure Global Plasma Protein Price (2013-2018)

Figure Global Fusion Proteins Sales Growth (2013-2018)

Figure Global Fusion Proteins Price (2013-2018)

Figure Global Monoclonal Antibodies Sales Growth (2013-2018)

Figure Global Monoclonal Antibodies Price (2013-2018)

Figure Global Hormones Sales Growth (2013-2018)

Figure Global Hormones Price (2013-2018)

Figure Global Enzyme Sales Growth (2013-2018)

Figure Global Enzyme Price (2013-2018)

Figure Global Coagulation Factors Sales Growth (2013-2018)

Figure Global Coagulation Factors Price (2013-2018)

Figure Global Others Sales Growth (2013-2018)

Figure Global Others Price (2013-2018)

Table Global Recombinant Therapeutic Antibodies and Proteins Sales by Application (2013-2018)

Table Global Recombinant Therapeutic Antibodies and Proteins Sales Share by Application (2013-2018)

Figure Global Hematology Sales Growth (2013-2018)

Figure Global Immunology Sales Growth (2013-2018)

Figure Global Endocrinology Sales Growth (2013-2018)

Figure Global Infectious Disease Sales Growth (2013-2018)

Figure Global Cardiovascular Disease Sales Growth (2013-2018)

Figure Global Others Sales Growth (2013-2018)

Figure Global Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Growth Rate (2018-2023)

Table Global Recombinant Therapeutic Antibodies and Proteins Sales Forecast by Regions (2018-2023)

Table Global Recombinant Therapeutic Antibodies and Proteins Market Share Forecast by Regions (2018-2023)

Figure North America Sales Recombinant Therapeutic Antibodies and Proteins Market Forecast (2018-2023)

Figure Europe Sales Recombinant Therapeutic Antibodies and Proteins Market Forecast (2018-2023)

Figure Asia-Pacific Sales Recombinant Therapeutic Antibodies and Proteins Market Forecast (2018-2023)

Figure South America Sales Recombinant Therapeutic Antibodies and Proteins Market Forecast (2018-2023)

Figure Middle East and Africa Sales Recombinant Therapeutic Antibodies and Proteins Market Forecast (2018-2023)

Table Global Recombinant Therapeutic Antibodies and Proteins Sales Forecast by Type (2018-2023)

Table Global Recombinant Therapeutic Antibodies and Proteins Market Share Forecast by Type (2018-2023)

Table Global Recombinant Therapeutic Antibodies and Proteins Sales Forecast by Application (2018-2023)

Table Global Recombinant Therapeutic Antibodies and Proteins Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List